CARDIOLITE

TETRAKIS(2-METHOXYISOBUTYLISOCYANIDE)COPPER(I) TETRAFLUOROBORATE · Lantheus Medical Imaging, Inc.

Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for CARDIOLITE, covering 2008-04-30 to 2019-12-04. Get the full timeline:

Most recent: FDA Approved: CARDIOLITE — Supplemental Application (Lantheus Medical Imaging, Inc.)